THE WHITE HOUSE
Office of the Press Secretary
PRESIDENT NAMES DR. ISADORE ROSENTHAL AS A MEMBER OF THE CHEMICAL SAFETY AND HAZARD INVESTIGATION BOARD
President Clinton today announced his intent to nominate Dr. Isadore (Irv) Rosenthal as the fifth member of the Chemical Safety and Hazard Investigation Board. Dr. Rosenthal spent the first 25 years of his career in the chemical industry with Rohm and Haas Company. He was Corporate Director of Safety, Health, Environmental Affairs and Product Integrity for 13 years. Since his retirement from Rohm and Haas in 1990, Dr. Rosenthal has been a Senior Fellow at the Wharton Risk and Decisions Processes Center at the University of Pennsylvania. Dr. Rosenthal holds a Ph.D. in physical chemistry from Pennsylvania State University.
Earlier this summer, President Clinton announced his nomination of Dr. Paul Hill to be the Chairperson and Chief Executive Officer of the Chemical Safety and Hazard Investigation Board and Dr. Devra Lee Davis and Dr. Gerald V. Poje to be members of the Board. In addition, he announced his intent to nominate Dr. Andrea Kidd Taylor as the other member of the Board. Each Board member serves on a full-time basis for a term of five years.
Dr. Paul Hill is President of the National Institute for Chemical Studies in Charleston, West Virginia.
Dr. Devra Lee Davis is the Senior Advisor to the Assistant Secretary for Health, U.S. Department of Health and Human Services.
Dr. Gerald V. Poje is an expert with the National Institute of Environmental Health Sciences in Bethesda, Maryland.
Dr. Andrea Kidd Taylor is an International Representative and Industrial Hygienist with the United Auto Workers in Detroit, Michigan.
The Chemical Safety and Hazard Investigation Board was established under the Clean Air Act Amendments of 1990. The Board will be responsible for investigating the cause of chemical accidents and making recommendations to Congress, federal agencies, state and local agencies, and other interested parties. In addition, the Board will propose corrective steps to reduce the risk of injury in the production and use of chemicals and may conduct related research and studies. If confirmed by the Senate, these individuals would be the first members of the Board.